Matches in Nanopublications for { ?s ?p "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP277987.RA3bkdxO3siGCaCTTnhhZouqaD1VPTIt8TpJG9REerPT0130_assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277987.RA3bkdxO3siGCaCTTnhhZouqaD1VPTIt8TpJG9REerPT0130_provenance.
- assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP144185.RAYts2OR67aKQFa3NKOpLxyzVRbVm6u5e_f1Jp0g9ix3s130_assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP144185.RAYts2OR67aKQFa3NKOpLxyzVRbVm6u5e_f1Jp0g9ix3s130_provenance.
- NP110749.RAtX1mNQlciwaJpoaMrK0f_A6ATq5n87_OWv2IIeEF0aM130_assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP110749.RAtX1mNQlciwaJpoaMrK0f_A6ATq5n87_OWv2IIeEF0aM130_provenance.
- NP94534.RAVe82Q7x5ygFwrbvIZ2S625g10uskMBw4c5ZQPNMwADI130_assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94534.RAVe82Q7x5ygFwrbvIZ2S625g10uskMBw4c5ZQPNMwADI130_provenance.
- NP144250.RADRaB4mY9ShBqORJ4UmSNFzvhmKoQqMixdA5iW7-wTKw130_assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP144250.RADRaB4mY9ShBqORJ4UmSNFzvhmKoQqMixdA5iW7-wTKw130_provenance.
- NP60008.RAHsyjPwt2nFA1onV2ONDFXI2Ax6czUWu1K8oQD56HQbQ130_assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP60008.RAHsyjPwt2nFA1onV2ONDFXI2Ax6czUWu1K8oQD56HQbQ130_provenance.
- NP94535.RAhTTIQiO-mRFU6VJapGBix6DuWDJMXgj1C_JXtjHc4uQ130_assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94535.RAhTTIQiO-mRFU6VJapGBix6DuWDJMXgj1C_JXtjHc4uQ130_provenance.
- NP94537.RAkmv-uQadlgCIDKZIKs0qMXgKx22KOy0zLXB4JPs7KqA130_assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94537.RAkmv-uQadlgCIDKZIKs0qMXgKx22KOy0zLXB4JPs7KqA130_provenance.
- NP94536.RA1PIb8c0-W4M5s7hexCKjtqUNpk08jtIeU3fQjElTpMs130_assertion description "[Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP94536.RA1PIb8c0-W4M5s7hexCKjtqUNpk08jtIeU3fQjElTpMs130_provenance.